{
  "schema_version": 1,
  "kind": "drug_profile",
  "generic": "selenium sulfide",
  "review_status": "reviewed",
  "origin": "openfda",
  "sections": {
    "adult": [
      {
        "text": "See application instructions on rear panel of this bottle. For treatment of dandruff and seborrheic dermatitis: For the usual case, two applications each week for two weeks will afford control. After this, the suspension may be used at less frequent intervals - weekly, every two weeks, or even every 3 or 4 weeks in some cases. The preparation should not be applied more frequently than required to maintain control.",
        "source": "US FDA label for selenium sulfide (SELENIUM SULFIDE), section 'dosage and administration', retrieved 2026-08-29",
        "cached_file": "labels/selenium-sulfide.json",
        "verbatim": true
      }
    ],
    "child": [
      {
        "text": "Safety and effectiveness in infants have not been established.",
        "source": "US FDA label for selenium sulfide (SELENIUM SULFIDE), section 'pediatric use', retrieved 2026-08-29",
        "cached_file": "labels/selenium-sulfide.json",
        "verbatim": true
      }
    ],
    "renal": [
      {
        "text": "No kidney-impairment dose in this label. Not a statement that none is needed.",
        "source": "Read and found silent: the US FDA label for selenium sulfide (SELENIUM SULFIDE), retrieved 2026-08-29",
        "cached_file": "labels/selenium-sulfide.json",
        "verbatim": false
      }
    ],
    "hepatic": [
      {
        "text": "No liver-impairment dose in this label. Not a statement that none is needed.",
        "source": "Read and found silent: the US FDA label for selenium sulfide (SELENIUM SULFIDE), retrieved 2026-08-29",
        "cached_file": "labels/selenium-sulfide.json",
        "verbatim": false
      }
    ],
    "pregnancy": [
      {
        "text": "WHEN USED ON BODY SURFACES FOR THE TREATMENT OF TINEA VERSICOLOR, SELENIUM SULFIDE IS CLASSIFIED AS PREGNANCY CATEGORY \"C\".",
        "source": "US FDA label for selenium sulfide (SELENIUM SULFIDE), section 'pregnancy', retrieved 2026-08-29",
        "cached_file": "labels/selenium-sulfide.json",
        "verbatim": true
      },
      {
        "text": "Animal reproduction studies have not been conducted with Selenium Sulfide Topical Suspension USP, 2.5% (Lotion).",
        "source": "US FDA label for selenium sulfide (SELENIUM SULFIDE), section 'pregnancy', retrieved 2026-08-29",
        "cached_file": "labels/selenium-sulfide.json",
        "verbatim": true
      },
      {
        "text": "It is also not known whether Selenium Sulfide Topical Suspension USP, 2.5% (Lotion) can cause fetal harm when applied to body surfaces of a pregnant woman or can affect reproduction capacity.",
        "source": "US FDA label for selenium sulfide (SELENIUM SULFIDE), section 'pregnancy', retrieved 2026-08-29",
        "cached_file": "labels/selenium-sulfide.json",
        "verbatim": true
      }
    ],
    "lactation": [
      {
        "text": "Nothing on breastfeeding in this label. Treat as unknown, not as safe.",
        "source": "Read and found silent: the US FDA label for selenium sulfide (SELENIUM SULFIDE), retrieved 2026-08-29",
        "cached_file": "labels/selenium-sulfide.json",
        "verbatim": false
      }
    ]
  }
}